Human Health and Potential (HHP)

Data shows that antibodies produced as part of the COVID-19 immune response can neutralize a more transmissible variant of SARS-CoV-2.

Tracking how SARS-CoV-2 interacts with host cell receptors during infections may give us new ideas for COVID-19 drug targets.

Scientists identify a key molecular marker of muscle stem cells, providing novel insights into the mechanisms around muscle regeneration.

A novel 3D printing method developed by A*STAR researchers fabricates soft support for tissue growth, with embedded channels that ensure nutrient supply.

Some neutralizing antibodies against SARS-CoV-2 may heighten lung tissue damage from COVID-19, an A*STAR study finds.

Using a large-scale siRNA screen and CRISPR-Cas9 technology, researchers have pinpointed genes that can enhance antibody production in Chinese hamster ovary cells.

Precise and efficient C:G to G:C gene-editing enzymes could pave the way for new treatments for genetic diseases.

A scalable cell culture platform can generate universal red blood cells from stem cells, paving the way for manufacturing an abundant supply of blood for transfusions.

From forming protective physical barriers to stabilizing mRNA vaccines, polymers provide endless solutions to the threat of coronaviruses and other current and impending diseases.

Scientists develop a technique for performing advanced infrared microscopy using off-the-shelf cameras built for visible light.

To see skin in its full, three-dimensional glory, it first needs to be transparent.

The amount of neutralizing antibodies produced by COVID-19 patients—and the length of time they remain detectable—can vary wildly, a study suggests.